Information on COVID-19 Therapeutics for Medical Providers
As the latest guidance for COVID-19 therapeutics continues to evolve, SCHA wants to ensure that prescribers have the latest information. The following guidance includes the latest therapeutics update provided by DHEC on April 4, 2022.
General Information
Guidance on prescribing of and prioritization of patients to receive COVID-19 therapeutics is available from the NIH COVID-19 Treatment Guidelines.
HHS has created a website to help locate treatment options. This site currently shows locations for Evusheld, molnupiravir, and Paxlovid. They hope to soon have all therapeutics visible on this site.
If you are interested in becoming a provider for one or more of these therapeutics, please complete this form. As more supply becomes available, we will be adding additional sites. Once reviewed you will be contacted by someone from the DHEC Team about how to register for the proper federal sites required for daily and weekly reporting.
For assistance or more information please contact COVID19DRUG@dhec.sc.gov.
Monoclonal Antibodies
Regen-COV and Bam/Ete are unlikely to retain activity against Omicron, according to the FDA. As such on 1/24/22 HHS and the FDA announced Lilly’s bamlanivimab plus etesevimab and Regeneron’s casirivimab plus imdevimab (REGEN-COV) are not currently authorized for use anywhere in the U.S., due to the prevalence of Omicron.
Sotrovimab & BA.2 – FDA has limited the use of sotrovimab in regions of high BA.2 variant prevalence. This now includes R1, R2, R5, R9, and R10. Therefore, sotrovimab is no longer authorized for use at this time in the following states and territories: R1: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont R2: New Jersey, New York, Puerto Rico, the Virgin Islands R5: Illinois, Indiana, Michigan, Minnesota, Ohio, Wisconsin R9: Arizona, California, Hawaii, Nevada, Guam, American Samoa, Commonwealth of Northern Mariana Islands, Republic of Marshall Islands, Federated States of Micronesia R10: Alaska, Idaho, Oregon, Washington. It is available at 45 sites statewide (see table below).
| LOWCOUNTRY | UPSTATE |
| BEAUFORT MEMORIAL HOSPITAL | ABBEVILLE AREA MEDICAL CENTER |
| COASTAL CAROLINA HOSPITAL | ANMED HEALTH MEDICAL CENTER |
| HAMPTON REGIONAL MEDICAL CENTER | NETWORK HEALTHCARE |
| HILTON HEAD HEALTH AND WELLNESS | PHARMERICA EASLEY |
| LIBERTY DOCTORS, LLC | PRIMARY CARE OF UNION, PC |
|
MUSC UNIVERSITY HOSPITAL |
PRISMA HEALTH – UPSTATE PHARMACY
DISTRIBUTION CENTER |
| RSFH BON SECOURS ST. FRANCIS HOSPITAL | SELF REGIONAL HEALTHCARE |
| RSFH MONCKS CORNER MEDICAL PLAZA
(VIA RSFH MOUNT PLEASANT HOSPITAL) |
SIRI CANCER BLOOD AND INFUSION CENTER |
| RSFH ROPER HOSPITAL | SPARTANBURG REGIONAL HEALTH SYSTEM |
| THE REGIONAL MEDICAL CENTER | ST FRANCIS HOSPITAL DOWNTOWN |
| TOTAL WELLNESS MEDICAL CARE | ST FRANCIS EASTSIDE HOSPITAL |
| TRIDENT MEDICAL CENTER | WHITE OAK PHARMACY |
| PEE DEE | MIDLANDS |
| CARESOUTH CAROLINA | KERSHAW MEDICAL CENTER |
| CAROLINA PINES REGIONAL MEDICAL CENTER | LEXINGTON MEDICAL CENTER |
| CONWAY MEDICAL CENTER | MACKEY FAMILY PRACTICE |
|
MCLEOD HEALTH CHERAW HOSPITAL |
MUSC COLUMBIA MEDICAL CENTER
DOWNTOWN |
| MCLEOD HEALTH CLARENDON HOSPITAL | MUSC HEALTH LANCASTER MEDICAL CENTER |
| MCLEOD LORIS SEACOAST HOSPITAL (LORIS) | ONSITE CARE LLC |
| MCLEOD LORIS SEACOAST HOSPITAL (LITTLE
RIVER/SEACOAST) |
PIEDMONT MEDICAL CENTER |
| MCLEOD REGIONAL MEDICAL CENTER | PRISMA HEALTH MIDLANDS |
|
MUSC HEALTH FLORENCE MEDICAL CENTER |
PRUITTHEALTH PHARMACY SERVICES OF
LEXINGTON |
| MUSC HEALTH MARION MEDICAL CENTER | |
| TIDELANDS GEORGETOWN/WACCAMAW
COMMUNITY HOSPITAL |
|
| WILLIAMSBURG REGIONAL HOSPITAL |
Evusheld is currently available through 14 sites across the state as pre-exposure prophylaxis (PrEP) for immunocompromised patients who may not mount an adequate immune response to vaccination or are not able to be fully vaccinated with any available COVID-19 vaccine due to severe adverse reactions. South Carolina has been allocated a limited number of doses thus far, but as more product becomes available, more sites will be added.
For providers to refer patients for treatment, please contact (do not share this outside of providers):
- Lexington Medical Center (LMC Infusion Center: 803-791-2287)
- McLeod Health (Infusion and Treatment Info)
- MUSC Health Charleston (Infusion Center)
- Piedmont Medical Center (Beginning week of 1/24/22, Dr. Arash Poursina 803-324-3500)
- Prisma Midlands Richland (803-434-4717)
- Prisma Upstate-Greenville Ambulatory Infusion Center (864-455-6743)
- Roper Hospital (RSFH Antibody Infusion)
- Spartanburg Regional (GIC Central Scheduling, 864-560-1865)
- St. Francis Cancer Center (864-603-6200)
- Trident Medical Center (TBD)
- Articularis Healthcare Low Country Rheumatology (843-572-4840)
- Columbia Arthritis Center (803-779-0911)
- Affinity Healthcare – Rock Hill (803-909-6363)
- Greenwood Rheumatology (886-330-2054)
Oral Anti-viral Drugs
DHEC is encouraging providers to use oral antivirals more freely within the EUA limits.
Molnupiravir and Paxlovid are currently available at Walgreens across the state. These products do require a prescription from a medical provider and must be prescribed in accordance with the Emergency Use Authorization from the FDA. In addition, Ingles Pharmacy locations will also begin receiving antivirals. Fact sheets for providers are available for both molnupiravir and Paxlovid.
They should not be prescribed to patients to have “on hand” in case they test positive or become sick. Provider offices only may contact a Walgreens representative at (866) 935-0867 to help identify locations with antivirals in stock in the state. If a patient is not close to one of these 24-hour locations or has does not have transportation, Walgreens will ship it for free to the patient, overnight via FedEx. Please only provide this number to providers!
Prescribing providers may use results from OTC COVID tests, providing they document in the patient’s record a picture of the test results or the actual test results were viewed by prescribing providers staff and the patient attested that the results belong to them.
|
In addition, HRSA is also distributing Molnupiravir and Paxlovid directly to select Federally Qualified Health Centers. Those sites can be found on their website.
Test to Treat Program
A newly launched nationwide Test to Treat initiative gives individuals an important way to rapidly access free lifesaving treatment for COVID-19. In this program, people are able to get tested and – if they are positive and treatments are appropriate for them – receive a prescription from a health care provider, and have their prescription filled all in one location. These “One-Stop Test to Treat” sites will be available at hundreds of locations nationwide, including pharmacy-based clinics, federally-qualified community health centers (FQHCs), and long-term care facilities.
Currently there are 44 CVS locations that have been onboarded.
| CVS Store #00830 | 900 ASSEMBLY ST. CVS Pharmacy | COLUMBIA | |
| CVS Store #04026 | 1300 TIGER BLVD. CVS Pharmacy | CLEMSON | |
| CVS Store #07005 | 333 HWY 9 BYPASS CVS Pharmacy | LANCASTER | |
| CVS Store #01039 | 59 GEORGE ST. CVS Pharmacy | CHARLESTON | |
| CVS Store #05516 | 1303 38TH AVE. N. CVS Pharmacy | MYRTLE BEACH | |
| CVS Store #04489 | 1006 FORDING ISLAND ROAD CVS Pharmacy | BLUFFTON | |
| CVS Store #05549 | 1008 LAKE MURRAY BOULEVARD CVS Pharmacy | IRMO | |
| CVS Store #04204 | 301 N MAIN ST CVS Pharmacy | SUMMERVILLE | |
| CVS Store #02243 | 2566 ASHELY RIVER ROAD RTE 21 CVS Pharmacy | CHARLESTON | |
| CVS Store #05550 | 4724 CHARLOTTE HWY. CVS Pharmacy | CLOVER | |
| CVS Store #03888 | 200 HIGHWAY 25 NORTH CVS Pharmacy | TRAVELERS REST | |
| CVS Store #03113 | 1602 CENTRAL AVE. CVS Pharmacy | SUMMERVILLE | |
| CVS Store #03838 | 1405 EAST GREENVILLE STREET CVS Pharmacy | ANDERSON | |
| CVS Store #07061 | 5895 REIDVILLE RD. CVS Pharmacy | MOORE | |
| CVS Store #01540 | 3411 SOCASTEE BLVD. CVS Pharmacy | MYRTLE BEACH | |
| CVS Store #01571 | 1740 HWY 160 WEST CVS Pharmacy | FORT MILL | |
| CVS Store #07556 | 2401 SUNSET BOULEVARD CVS Pharmacy | WEST COLUMBIA | |
| CVS Store #07016 | 10317 OCEAN HIGHWAY 17 SOUTH CVS | PAWLEYS ISLAND | |
| CVS Store #05566 | 10 POPE AVENUE CVS Pharmacy | HILTON HEAD | |
| CVS Store #02192 | 698 FAIRVIEW ROAD CVS Pharmacy | SIMPSONVILLE | |
| CVS Store #05471 | 1071 S. LAKE DR. CVS Pharmacy | LEXINGTON | |
| CVS Store #07396 | 1010 HWY 17 NORTH CVS Pharmacy | N. MYRTLE BEACH | |
| CVS Store #04288 | 2707 CELANESE RD. CVS Pharmacy | ROCK HILL | |
| CVS Store #07012 | 1330 DUTCH FORK RD. CVS Pharmacy | IRMO | |
| CVS Store #02246 | 2210 LAURENS ROAD CVS Pharmacy | GREENVILLE | |
| CVS Store #05479 | 7697 CHARLOTTE HWY CVS Pharmacy | INDIAN LAND | |
| CVS Store #07334 | 5608 SUNSET BLVD. CVS Pharmacy | LEXINGTON | |
| CVS Store #04295 | 2062 WHISKEY ROAD CVS Pharmacy | AIKEN | |
| CVS Store #04122 | 3300 WADE HAMPTON BOULEVARD CVS | TAYLORS | |
| CVS Store #07567 | 1888 BOILING SPRINGS ROAD CVS Pharmacy | BOILING SPRINGS | |
| CVS Store #04286 | 5269 CALHOUN MEMORIAL HWY CVS Pharmacy | EASLEY | |
| CVS Store #04382 | 1751 EAST MAIN STREET CVS Pharmacy | SPARTANBURG | |
| CVS Store #02250 | 121 CLEMSON RD CVS Pharmacy | COLUMBIA | |
| CVS Store #02269 | 4310 HARDSCRABBLE ROAD CVS Pharmacy | COLUMBIA | |
| CVS Store #02736 | 3710 HIGHWAY 17 BYPASS CVS Pharmacy | MURRELLS INLET | |
| CVS Store #02242 | 2580 WOODRUFF ROAD CVS Pharmacy | SIMPSONVILLE | |
| CVS Store #07397 | 3901 PELHAM RD. CVS Pharmacy | GREENVILLE | |
| CVS Store #07654 | 2996 E. HWY 501 CVS Pharmacy | CONWAY | |
| CVS Store #02194 | 224 EAST BUTLER ROAD CVS Pharmacy | MAULDIN | |
| CVS Store #07537 | 5215 ASHLEY PHOSPHATE RD. CVS Pharmacy | N. CHARLESTON | |
| CVS Store #00626 | 8995 UNIVERSITY BLVD CVS Pharmacy | N. CHARLESTON | |
Anti-viral Drug
VEKLURYTM (remdesivir) is not allocated by the federal government and is available to be ordered commercially from AmerisourceBergen. Following the recent statement from the National Institutes of Health (NIH) COVID-19 Treatment Guidelines Panel regarding therapies for the COVID-19 Omicron variant, CMS created HCPCS code J0248 for VEKLURY™ (remdesivir) antiviral medication when administered in an outpatient setting. This code is available for use by all payers and is effective for dates of service on or after December 23, 2021:
- Long descriptor: Injection, remdesivir, 1 mg
- Short descriptor: Inj, remdesivir, 1 mg
Therefore, the MACs will determine Medicare coverage for HCPCS code J0248 for VEKLURY™.